Aronson, S. L. https://orcid.org/0000-0001-7262-1015
Thijssen, B. https://orcid.org/0000-0003-1562-2649
Lopez-Yurda, M. https://orcid.org/0000-0003-3678-3222
Koole, S. N.
van der Leest, P. https://orcid.org/0000-0001-8527-4956
León-Castillo, A.
Harkes, R.
Seignette, I. M. https://orcid.org/0009-0007-7757-698X
Sanders, J. https://orcid.org/0000-0002-0551-7813
Alkemade, M.
Kemper, I.
Holtkamp, M. J.
Mandjes, I. A. M.
Broeks, A.
Lahaye, M. J.
Rijlaarsdam, M. A.
van den Broek, D.
Wessels, L. F. A. https://orcid.org/0000-0002-1656-6995
Horlings, H. M. https://orcid.org/0000-0003-4782-8828
van Driel, W. J. https://orcid.org/0000-0003-2246-1994
Sonke, G. S. https://orcid.org/0000-0001-8088-9628
Funding for this research was provided by:
The study was funded by MSD
Article History
Received: 22 October 2024
Accepted: 24 March 2025
First Online: 14 April 2025
Competing interests
: G.S.S. has received institutional research support from MSD, Agendia, AstraZeneca, Roche, and Novartis, and consulting fees from Biovica and Seagen. The remaining authors declare no competing interests.